📰 Neuronetics Daily News
Neuronetics Daily News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Neuronetics Daily. Real-time updates on events, politics, business and more.
June 7, 2024
Neuronetics, Inc. (NASDAQ:STIM – Get Free Report) Director Robert Cascella acquired 50,000 shares of the firm’s stock in a transaction on Thursday, June 6th. The shares were bought at an average cost of $2.05 per share, with a total value of $102,500.00. Following the completion of the transaction, the director now directly owns 244,098 shares […]
June 7, 2024
Neuronetics, Inc. (NASDAQ:STIM – Get Free Report) Director Robert Cascella bought 50,000 shares of Neuronetics stock in a transaction on Thursday, June 6th. The stock was acquired at an average price of $2.05 per share, with a total value of $102,500.00. Following the completion of the purchase, the director now directly owns 244,098 shares of […]
May 31, 2024
Neuronetics, Inc. (NASDAQ:STIM – Get Free Report) saw a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 18,000 shares, a decline of 69.1% from the April 30th total of 58,300 shares. Based on an average daily trading volume, of 176,600 shares, the days-to-cover ratio […]
May 7, 2024
Fielder Capital Group LLC bought a new stake in Neuronetics, Inc. (NASDAQ:STIM – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 22,797 shares of the company’s stock, valued at approximately $66,000. Fielder Capital Group LLC owned approximately 0.08% of Neuronetics at […]
May 7, 2024
Fielder Capital Group LLC bought a new stake in shares of Neuronetics, Inc. (NASDAQ:STIM – Free Report) in the fourth quarter, Holdings Channel reports. The institutional investor bought 22,797 shares of the company’s stock, valued at approximately $66,000. Other large investors also recently bought and sold shares of the company. FNY Investment Advisers LLC purchased […]
April 12, 2024
Neuronetics, Inc. (NASDAQ:STIM – Get Free Report) saw a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 94,600 shares, a growth of 77.8% from the March 15th total of 53,200 shares. Based on an average daily volume of 199,100 shares, the days-to-cover ratio is […]
March 27, 2024
William Blair reissued their market perform rating on shares of Neuronetics (NASDAQ:STIM – Free Report) in a research note published on Tuesday morning, RTT News reports. Separately, Piper Sandler reaffirmed an overweight rating and issued a $8.00 target price (up from $7.00) on shares of Neuronetics in a research note on Wednesday, March 6th. Read […]
March 26, 2024
Neuronetics (NASDAQ:STIM – Get Free Report)‘s stock had its “market perform” rating restated by William Blair in a note issued to investors on Tuesday, RTT News reports. Separately, Piper Sandler reiterated an “overweight” rating and issued a $8.00 target price (up previously from $7.00) on shares of Neuronetics in a research report on Wednesday, March […]
March 26, 2024
Neuronetics (NASDAQ:STIM – Get Free Report)‘s stock had its “market perform” rating restated by analysts at William Blair in a research note issued on Tuesday, RTT News reports. Separately, Piper Sandler reaffirmed an “overweight” rating and issued a $8.00 price target (up from $7.00) on shares of Neuronetics in a report on Wednesday, March 6th. […]
February 29, 2024
Neuronetics, Inc. (NASDAQ:STIM – Get Free Report) CEO Keith J. Sullivan sold 20,851 shares of the business’s stock in a transaction that occurred on Thursday, February 22nd. The shares were sold at an average price of $3.23, for a total value of $67,348.73. Following the completion of the transaction, the chief executive officer now directly […]